SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE: CTLT) (“Catalent”), the leading global provider of
advanced delivery technologies and development solutions for drugs,
biologics, and consumer health products, today announced that it will
release financial results for the third quarter of fiscal year 2018
ended March 31, 2018, before the market open on Tuesday, May 1, 2018.
The Company’s management will host a webcast to discuss the results at
8:15 a.m. ET on the same day.
Catalent invites all interested parties to listen to the webcast, which
will be accessible through Catalent’s website at http://investor.catalent.com.
A supplemental slide presentation will also be available in the
“Investors” section of Catalent’s website prior to the start of the
The webcast replay, along with the supplemental slides, will be
available for 90 days in the “Investors” section at www.catalent.com.
About Catalent, Inc.
Catalent is the leading global provider of advanced delivery
technologies and development solutions for drugs, biologics and consumer
health products. With over 80 years serving the industry, Catalent has
proven expertise in bringing more customer products to market faster,
enhancing product performance and ensuring reliable clinical and
commercial product supply. Catalent employs over 10,000 people,
including over 1,400 scientists, at more than 30 facilities across 5
continents and in fiscal 2017 generated more than $2 billion in annual
revenue. Catalent is headquartered in Somerset, N.J. For more
information visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
Thomas Castellano, 732-537-6325